Related Experiment Video
Updated: Nov 22, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Disease-modifying antirheumatic drugs and organising pneumonia
Mohamed Faisal1, Asyraf Roslan1, Nik Nuratiqah Nik Abeed1
1Respiratory Unit, Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Kuala Lumpur, Malaysia.
Abstract:
Organising pneumonia (OP) in rheumatoid arthritis (RA) may be part of pulmonary manifestation (disease related) or disease-modifying antirheumatic drugs (DMARDs) related. We report a case series of RA patients with DMARDs related OP. A 65-year-old woman developed OP 3 weeks after initiation of methotrexate (MTX). High-resolution CT (HRCT) scan of the thorax revealed bilateral consolidations in the lung bases. She had complete radiological resolution 6 months after corticosteroid therapy with cessation of MTX. The second case was of a 60-year-old woman on MTX with recent addition of leflunomide due to flare of RA. She developed worsening cough 4 months later and HRCT scan revealed consolidation in the left upper lobe with biopsy proven OP. She responded within 6 months of corticosteroid therapy with clinical and radiological resolution. This case series highlights that OP may developed with low-dose MTX (as early as 3 weeks) and leflunomide and the diagnosis requires a high index of suspicion.
Insights
Rheumatoid arthritis patients can develop organizing pneumonia (OP) due to medications like methotrexate and leflunomide. Early diagnosis and treatment with corticosteroids lead to recovery.
Area of Science:
- Rheumatology
- Pulmonology
- Pharmacology
Background:
- Organizing pneumonia (OP) in rheumatoid arthritis (RA) can be disease-related or drug-induced.
- Disease-modifying antirheumatic drugs (DMARDs) are commonly used to manage RA.
- Identifying drug-related pulmonary complications is crucial for patient management.
Observation:
- A case series of two RA patients experiencing OP attributed to DMARDs.
- Patient 1 developed OP 3 weeks after starting methotrexate (MTX).
- Patient 2 developed OP while on MTX and leflunomide.
Findings:
- High-resolution CT (HRCT) scans showed bilateral consolidations in one patient and left upper lobe consolidation in the other.
- Both patients achieved complete radiological and clinical resolution with corticosteroid therapy and drug cessation/modification.
- OP can occur with low-dose methotrexate and leflunomide, even early in treatment.
Implications:
- This case series underscores the importance of considering drug-induced OP in RA patients presenting with pulmonary symptoms.
- A high index of suspicion is necessary for timely diagnosis and effective management.
- Understanding the potential pulmonary side effects of RA medications is vital for clinicians.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

